tirzepatide vs retatrutide vs. Tirzepatide: The Next-Gen GLP-1 Showdown Semaglutide vs Tirzepatide vs Retatrutide:

Category 2 designation means the FDA identified these substances as presenting potential safety concerns and deemed them not currently eligible for routine compounding under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act

P., Wu, Q., Du, Y., Gurbuz, S., Coskun, T., Haupt, A., Milicevic, Z., & Hartman, M

Using only the injectable subcutaneous formulation

Overall, this study provided valuable insight into the use of high dose semaglutide for weight reduction in diabetic patients

PlexusDx serves adults 18 and over nationwide, offering semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance required